🌟 Join our LinkedIn community! 🌟 Stay updated with the issue releases, published articles, and the latest news in the scholarly field. Follow us today and be part of a network that’s shaping the future. 🔗 https://lnkd.in/gEHPmDKQ
Pharmacy Group Journals
Book and Periodical Publishing
Hyderabad, Telangana 42 followers
Bridging science and healthcare: Connecting with pharmacists and pharmaceutical professionals
About us
Bridging the gap between science and patient care. This group connects pharmacists, researchers, and healthcare professionals to discuss medication development, pharmacy practice, and drug interactions. Share knowledge, stay updated on new drugs, and collaborate to optimize patient care
- Website
-
www.pharmascigroup.com
External link for Pharmacy Group Journals
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Hyderabad, Telangana
- Founded
- 2014
- Specialties
- Pharmacist, Pharmacology, Pharmaceutical Sciences, Drug Discovery, and Medicinal Chemistry
Updates
-
📢 Stay in the loop with all our latest updates! 🚀 Follow our Page to stay up-to-date with the latest news, announcements, and exciting developments. Don't miss out on any of the action – hit that follow button now! 🌟 #StayConnected #FollowUs #StayUpdated 📲👍
Pharmacy Group | LinkedIn
in.linkedin.com
-
Stay in the loop! Follow our page to keep up with the latest updates and news.
Pharmacy Group | LinkedIn
in.linkedin.com
-
https://lnkd.in/g3V8y4Dd Article Title: Cinnamon: A potent nutraceutical agent for the protection of the cardiovascular system Author(s): Taherah Mohammadabadi*, Asif Ur Rehman and Rajesh Jain Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: Diseases such as diabetes, atherosclerosis, and hypertension are risk factors for Cardiovascular Diseases (CVDs). About 17.3 million deaths worldwide were due to CVDs in 2013 and is anticipated to be 23.3 million by 2030. Common therapies for CVDs are associated with wide side effects. Thus, herbal medicines have been regarded more due to fewer side effects, availability, cultural beliefs, and being cheap. For thousands of years, herbal medicine has been used for bacterial infections, colds, coughs, and CVDs. #Cardiovasculardisease #Cinnamon #Nutraceutica #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gaMV3hQw Article Title: Mycobacterium abscessus subsp. Bolletti-associated osteomyelitis of the lumbar vertebrae in immunocompetent patient Author(s): Anda Vīksna, Jānis Zeltiņš, Guntars Mauriņš, Vija Riekstiņa and Iveta Ozere* Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: Introduction: Nontuberculous mycobacteria (NTM)-related Vertebral Osteomyelitis (VO) is a rare disease with challenging diagnosis and management. NTM-caused disease more often develops in vulnerable populations, affecting individuals who are immunocompromised or who have underlying health conditions. #Nontuberculousmycobacteria #Vertebralosteomyelitis #Mycobacteriumabscessus#Spondylodiscitis #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gHcc-DiV Article Title: Validated method for estimation of ethamsylate by UV-spectroscopy Author(s): Sanjay Kumar Karan* and Subhasmita Subhadarshinee Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: For the estimation of ethamsylate in pharmaceutical tablet dosage forms an accurate, simple, efficient spectrophotometric method was developed and validated. It showed absorption maxima at 300 nm with distilled water. According to ICH guidelines, the method was validated concerning specificity, linearity, accuracy, and precision. Ethamsylate’s linearity and range were found to be 5 to 50 μg/ml, with a correlation coefficient of 0.999. The analysis's findings were verified statistically and estimation of ethamsylate was done in marketed formulation. #Ethamsylate #UVvisiblespectrophotometer #Validationmethods #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gxs7kQpu Article Title: Visualization of the obscure inhalation stage in inhalation therapy Author(s): Hiroyuki Ohbayashi* Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: The flow of the inhalation procedure during inhalation therapy can be divided into three successive stages: a pre-inhalation preparatory stage, a drug inhalation stage, and a post-inhalation stage. Among these, the second stage, drug inhalation, is the most important and obscure. Using ambiguous verbal expression, the drug inhalation method is communicated to the patient using terms such as strongly, deeply, and slowly. Patients usually determine their optimal method of drug inhalation device independently, based on their own interpretation and understanding of the verbal instructions. This may make the precise inhalation using an inhalation device unpredictable. The Tokico Inhalation Monitor TM (TIM) was developed to resolve the unpredictability of this second (drug inhalation) stage. The TIM can simultaneously measure the inhalation flow rate, duration, and total volume, and display them on the screen in real-time. This mini-review demonstrates the effects of inhalation instruction using TIM, which allows the second stage of therapy, drug inhalation, to be displayed on a screen in real-time. #Asthma #Chronicobstructivepulmonarydisease #Inhalationtherapy #Inhalationmonitor #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gqGC3ESu Article Title: Physicochemical characterization and biological activity of polysaccharides from the seeds of the turnip Brassica rapa Author(s): Yuliya I Oshchepkova*, Мunojat J Oripova, Zulfizar N Kuzieva, Barno B Koraboeva, Dilnoza G Abdugafurova, Dilfuza A Amanlikova and Shavkat I Salikhov Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: Analysis of the monosaccharide composition showed that the composition of the neutral polysaccharide BSP-1-1 is represented by monosaccharides in the following composition: ribose – 5.05%, arabinose – 56.38%, mannose – 5.87%, glucose – 8.63% and galactose – 24.05%. The composition of the anionic polysaccharide BSP-2-1 is represented by monosaccharides: ribose – 6.35%, arabinose – 60.15%, mannose – 7.19%, glucose – 4.12% and galactose – 22.16%. It was determined that the isolated polysaccharides consist mainly of arabinose (BSP-1-1 – 56.3%, BSP-2-1 – 60%) and galactose (BSP-1-1 – 24%, BSP-2-1 – 22%). #Brassicarapa #Polysaccharides #Monosaccharidecomposition #IRspectroscopy #Diabetesmellitus #Alloxan #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gruaPcTE Article Title: Review on pharmacological therapies for management of gestational diabetes Author(s): Shabnam Akram*, Safia Bibi Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: The prevalence of Gestational Diabetes Mellitus (GDM) is increasing and is closely linked to numerous negative pregnancy outcomes. To mitigate these risks, early identification and management of GDM is critical. Treatment for GDM aims to maintain normal blood sugar levels and typically includes glucose monitoring, adjustments to diet, lifestyle changes, moderate physical activity, and medication as necessary. Insulin administration is generally the preferred choice for pharmacotherapy, but oral drugs such as metformin or glyburide may also be appropriate. Compared to glyburide, which has been linked to higher birth weight, neonatal hypoglycemia, raising the risk of shoulder dystocia, and necessitating a caesarean delivery, metformin is seen to be a safe first-line therapy. It should be emphasized that some expecting mothers choose complementary and alternative therapies, such as traditional herbal supplements and treatments. This review article will address present pharmacological options and considerations associated with treating GDM. #Gestation #Diabetes #Management #Therapies #GDM #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials
-
https://lnkd.in/gQM_N5GE Article Title: Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature Author(s): Graziana Arborea*, Anna Maria Valentini, Stefania Marangi, Nicoletta Labarile LT and Maria Teresa Savino Journal: International Journal of Pharmaceutical Sciences and Developmental Research Journal ISSN: 2640-7760 Abstract: Dasatinib is a potent tyrosine kinase inhibitor, in disease states associated with BCR/ABL 1, approved in 2006 for chronic myeloid leukemia treatment. This agent has been shown to exhibit broad off-target kinase inhibition and immunomodulating properties. These effects may be responsible for common adverse reactions (> 15%) which include immunosuppression, cytopenias, pleural effusion and other fluid retention, diarrhea, and other gastrointestinal side effects. #Dasatinib #Colitis #Inflammatoryboweldisease #Chronicmyeloidleukemia #MedicinalChemistry #DrugDevelopment #Pharmacokinetics #Pharmacodynamics #Pharmacogenomics #Toxicology #Pharmaceutics #Biopharmaceutics #Pharmacognosy #PharmaceuticalChemistry #PharmacyPractice #CommunityPharmacy #HospitalPharmacy #IndustrialPharmacy #RegulatoryAffairs #DrugFormulation#DrugDelivery #PharmacyManagement #PharmaceuticalTechnology #PharmacyEducation #ClinicalTrials